Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
24.18
-1.59 (-6.17%)
Feb 4, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
T-cell Therapies
61.00K
T-cell Therapies Growth
-53.08%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
61.00K
United States Growth
-53.08%